Bosnia and Herzegovina vs Peru: Share of one-year-olds vaccinated against Haemophilus influenzae type B
Bosnia and Herzegovina
79.0%
in 2024
Peru
80.0%
in 2024
Bosnia and Herzegovina rank
145th
Peru rank
142nd
Share of one-year-olds vaccinated against Haemophilus influenzae type B over time
- Bosnia and Herzegovina
- Peru
How they compare
Peru currently reports 80.0% against 79.0% in Bosnia and Herzegovina, a difference of 1.0%.
The two have swapped places 2 times across 21 shared years of data; in 2004 it was Peru ahead.
Bosnia and Herzegovina ranks 145th and Peru ranks 142nd of 192 countries.
Peru has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bosnia and Herzegovina | Peru | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 71.2% | 93.8% | 22.7% | Peru |
| 2010s | 77.2% | 90.1% | 12.9% | Peru |
| 2020s | 76.0% | 80.0% | 4.0% | Peru |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of one-year-olds vaccinated against haemophilus influenzae type b, Bosnia and Herzegovina or Peru?
- Peru, at 80.0% against 79.0% in Bosnia and Herzegovina as of 2024.
- What is the difference in share of one-year-olds vaccinated against haemophilus influenzae type b between Bosnia and Herzegovina and Peru?
- 1.0%, with Peru ahead.
- How many years of comparable data are there for Bosnia and Herzegovina and Peru?
- 21 years are reported by both, from 2004 to 2024.
- How do Bosnia and Herzegovina and Peru rank globally for share of one-year-olds vaccinated against haemophilus influenzae type b?
- Bosnia and Herzegovina ranks 145th and Peru ranks 142nd of 192 countries.
- Where does this data come from?
- WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as Share of one-year-olds vaccinated against Haemophilus influenzae type B. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of one-year-olds who have had three doses of Haemophilus influenzae type b vaccine in a given year.